Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 227-033-5 | CAS number: 5613-46-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
An acute oral toxicity test on rats (OECD 425) and an acute dermal toxicity test on rats (OECD 402) were conducted under GLP to assess the acute toxicity of TMBPA. Data waiver for acute inhalation toxicity is included. Under the conditions of the studies, TMBPA was determined to have no significant acute toxicity.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- up-and-down procedure
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Five female Sprague-Dawley rats were received from Ace Animals, Inc., Boyertown, PA. Females were nulliparous and non-pregnant, were approximately 9-10 weeks old and weighed 169 to 189 g at study start. Animals were single housed from arrival to termination and were acclimated for 8 to 13 days prior to dosing. Filtered tap water was provided ad libitum throughout the study and feed was provided ad libitum, with the exception of overnight prior to dosing. The temperature and humidity were maintained at 19-21°C and 30-56%, respectively. Room lights were on a 12-hour light/dark cycle.
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- A tissue homogenizer was used to facilitate the preparation of a homogeneous mixture of the test substance in water. The test substance was administered as a 35% w/w mixture in distilled water (specific gravity = 1.060 g/mL). Preliminary solubility testing conducted by EPSL indicated mixtures in excess of 35% (i.e. 40% to 70%) were too viscous to be administered properly. Individual doses were calculated based on the initial body weights, taking into account the specific gravity and concentration of the test mixture.
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5 females
- Control animals:
- no
- Details on study design:
- A limit test was performed. Food was withheld from the animals the night prior to dosing. Animals were administered a single dose of TMBPA by oral gavage at 2000 mg/kg as follows: One animal was dosed at 2000 mg/kg. Since this animal survived, four additional animals were dosed at 2000 mg/kg. Since these four additional animals survived, no additional testing was conducted. After dosing, each animal was returned to their cage and feed and water were provided ad libitum approximately 3 to 4 hours after dosing. All animals were observed for mortality, signs of gross toxicity and behavioral changes at least once daily for 14 days following dosing. Body weights were recorded on Day 0, prior to dose administration, Day 7 and Day 14 (termination). A gross necropsy was performed on all animals at study termination.
- Statistics:
- No statistical tests were performed.
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- no animals died
- Clinical signs:
- No clinical manifestations of toxicity were observed over the course of the study.
- Body weight:
- All animals gained weight throughout the study.
- Gross pathology:
- No gross lesions were observed during necropsy.
- Other findings:
- none
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- Under the conditions of this study, Tetramethyl bisphenol A (TMBPA) was determined to have an acute oral LD50 of greater than 2000 mg/kg and was assigned Toxicity Category 5 per the OECD Globally Harmonized System of Classification and Labelling of Chemicals (GHS).
- Executive summary:
The acute oral toxicity of Tetramethyl Bisphenol A (TMBPA; CAS No. 5613-46-7) to female Sprague-Dawley rats was determined in an up-and-down acute oral toxicity study conducted at eurofins/Product Safety Laboratories, Dayton, NJ, USA. The study was conducted in compliance with OECD GLPs and according to the following test guidelines: OECD 425 (2006) and OPPTS 870.110 (2002).
Using the up-and-down procedure, a total of five female rats were dosed via oral gavage with the test substance at a concentration of 2000 mg/kg. A tissue homogenizer was used to facilitate the preparation of a homogeneous mixture of the test substance in water. The test substance was administered as a 35% w/w mixture in distilled water (specific gravity = 1.060 g/mL). Individual doses were calculated based on the initial body weights, taking into account the specific gravity and concentration of the test mixture.
No animals died and no clinical signs of toxicity were observed over the course of the study. All surviving animals gained weight throughout the study and no gross findings were observed at the terminal necropsy.
Under the conditions of this study, Tetramethyl bisphenol A (TMBPA) was determined to have an acute oral LD50 of greater than 2000 mg/kg and was assigned Toxicity Category 5 as per the OECD Globally Harmonized System of Classification and Labelling of Chemicals (GHS).
Reference
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1200 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Five male and five female Sprague-Dawley rats were received from Ace Animals, Inc., Boyertown, PA. Animals were approximately 8-9 weeks old and weighed 224-257 g (males) and 186 to 199 g (females) at study start. Females were nulliparous and non-pregnant. Animals were single housed from arrival to termination and were acclimated for 8 days prior to dose administration. Filtered tap water was provided ad libitum by an automatic water dispensing system and feed was provided ad libitum throughout the study. The temperature and humidity were maintained at 20-23°C and 38-66%, respectively. Room lights were on a 12-hour light/dark cycle.
- Type of coverage:
- occlusive
- Vehicle:
- water
- Details on dermal exposure:
- On the day prior to application, a group of naïve animals was prepared by clipping the dorsal area and the trunk. After clipping, the animals were examined for health, weighed and the skin checked for any abnormalities. In order to assure adequate contact of the test substance with the skin, the test substance was moistened with distilled water to produce a 70% w/w mixture, which appeared as a dry paste. The test substance mixture (2000 mg/kg body weight) was then applied to a 2-inch x 3-inch, 4-ply gauze pad and placed on a dose area of approximately 2 inches by 3 inches (approximately 10% of the body surface). The gauze pad and entire trunk of each animal were wrapped with 3-inch Durapore tape. The rats were then returned to their designated cages. After the 24 hour exposure period, the pads were removed and the test sites were gently cleansed of any residual test substance.
- Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg body weight
- No. of animals per sex per dose:
- 5
- Control animals:
- not required
- Details on study design:
- The animals were observed for mortality, signs of gross toxicity and behavioral changes during the first several hours after application and at least once daily thereafter for 14 days. The animals were observed for signs of erythema and edema after the exposure period according to the Draize Scale for Scoring Skin Reactions. Animals were weighed at Day 0 (prior to dose administration), Day 7 and Day 14 (termination). All animals were euthanized via CO2 inhalation on Day 14 and a gross necropsy was performed. Tissues and organs of the thoracic and abdominal cavities were examined.
- Statistics:
- Statistics: No statistical tests were performed.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No animals died over the course of this study.
- Clinical signs:
- No overt signs of toxicity were observed during the course of the study.
- Body weight:
- All animals gained weight during the post-treatment period.
- Gross pathology:
- No gross lesions were observed during necropsy.
- Other findings:
- none
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- Under the conditions of this study, Tetramethyl bisphenol A (TMBPA) was determined to have an acute dermal LD50 of greater than 2000 mg/kg and was assigned Toxicity Category 5 as per the OECD Globally Harmonized System of Classification and Labelling of Chemicals (GHS).
- Executive summary:
The acute dermal toxicity of Tetramethyl Bisphenol A (TMBPA; CAS No. 5613-46-7) was determined in a limit test study with male and female Sprague-Dawley rats conducted at eurofins/Product Safety Laboratories, Dayton, NJ, USA. The study was conducted in compliance with OECD GLPs and according to the following test guidelines: OECD 402 (1987) and EPA OPPTS 870.1200 (1998).
In order to assure adequate contact of the test substance with the skin, the test substance was moistened with distilled water to produce a 70% w/w mixture, which appeared as a dry paste. The test substance mixture (2000 mg/kg body weight) was then applied to the clipped backs of 5 male and 5 female rats. The application site was covered with an occlusive dressing for the 24-hour exposure period, after which the test sits were gently cleansed of any residual test substance. Animals were observed for 14 days post exposure.
All animals survived the study, no clinical signs of toxicity were observed and no signs of irritation were seen on the test sites. All animals gained weight during the post-treatment period.
Under the conditions of this study, Tetramethyl bisphenol A (TMBPA) was determined to have an acute dermal LD50 of greater than 2000 mg/kg and was assigned Toxicity Category 5 as per the OECD Globally Harmonized System of Classification and Labelling of chemicals (GHS).
Reference
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Under the conditions of these studies, Tetramethyl bisphenol A (TMBPA) was determined to have an acute oral LD50 of greater than 2000 mg/kg, and to have an acute dermal LD50 of greater than 2000 mg/kg. In accordance with Column 2 of Annex VIII (8.5), an acute inhalation study does not need to be conducted for substances other than gases if a study is available for the oral route (8.5.1), and at least one other route. As the substance is a solid and a dermal acute toxicity study is also available, the conditions required to justify a data waiver are met.
Justification for classification or non-classification
Based on the observed LD50 of >2000 mg/kg bw in the acute oral and dermal toxicity study, the test substance does not need to be classified according to Directive 67/548/EEC and according to the EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.